Please assess the completion status of the following clinical trial:

Trial Title: Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* at least 18 years of age with a diagnosis of facial seborrhoeic dermatitis~Exclusion Criteria:~* taking other systemic or topical treatments for facial seborrhoeic dermatitis within the previous 4 weeks~* a known allergy to the components of tacrolimus ointment~* malignant neoplasm; immunologic abnormality~* active infection~* other definitive cutaneous findings such as erythroderma, acne, and psoriasis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- vehicle twice weekly (Type: NO_INTERVENTION): None
- tacrolimus once weekly (Type: EXPERIMENTAL): None
- tacrolimus twice weekly (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).